Background Cardiovascular magnetic resonance can demonstrate myocardial processes in Fabry disease (FD), such as low native T1 (sphingolipid storage) and late gadolinium enhancement (LGE, scar). Recently, high T2 (edema) has been observed in the basal inferolateral wall along with troponin elevation. We hypothesized that edema and myocyte injury would be chronically associated and have electrical, mechanical, and disease associations in FD. Methods A prospective international multicenter study was conducted on 186 consecutive FD patients (45.2±1.1 years, 58% females). Additionally, 28 patients with hypertrophic cardiomyopathy, 30 with chronic myocardial infarction and 59 healthy volunteers were included. All study participants underwent com...
Skeletal muscle disturbances are commonly reported in patients with Fabry disease. Whether they deri...
Fabry disease (FD) is a genetic lysosomal storage disease with frequent cardiovascular involvement, ...
In the past few years, the wide application of cardiac magnetic resonance (CMR) significantly change...
Background Cardiovascular magnetic resonance can demonstrate myocardial processes in Fabry disease (...
Fabry disease (FD) is an X-linked inheritable storage disease caused by a deficiency of alpha-galact...
AIMS Cardiac involvement in Fabry disease (FD) occurs prior to left ventricular hypertrophy (LVH)...
BACKGROUND: Cardiovascular magnetic resonance (CMR) derived native myocardial T1 is decreased in pat...
Fabry disease (FD) is a rare lysosomal storage disorder also affecting the heart. The aims of this s...
BACKGROUND Cardiac response to enzyme replacement therapy (ERT) in Fabry disease is typically ass...
Background Fabry disease is characterized by a progressive deposition of sphingolipids in differe...
Fabry's disease is a multisystem X-linked disorder of lysosomal metabolism frequently associated wit...
Abstract Background Cardiac involvement is common and...
Abstract Although Fabry disease was identified a century ago, it is still a challenging condition to...
BackgroundCardiovascular disease is the most common cause of death among Fabry disease patients, who...
In spite of several research studies help to describe the heart in Fabry disease (FD), the cardiomyo...
Skeletal muscle disturbances are commonly reported in patients with Fabry disease. Whether they deri...
Fabry disease (FD) is a genetic lysosomal storage disease with frequent cardiovascular involvement, ...
In the past few years, the wide application of cardiac magnetic resonance (CMR) significantly change...
Background Cardiovascular magnetic resonance can demonstrate myocardial processes in Fabry disease (...
Fabry disease (FD) is an X-linked inheritable storage disease caused by a deficiency of alpha-galact...
AIMS Cardiac involvement in Fabry disease (FD) occurs prior to left ventricular hypertrophy (LVH)...
BACKGROUND: Cardiovascular magnetic resonance (CMR) derived native myocardial T1 is decreased in pat...
Fabry disease (FD) is a rare lysosomal storage disorder also affecting the heart. The aims of this s...
BACKGROUND Cardiac response to enzyme replacement therapy (ERT) in Fabry disease is typically ass...
Background Fabry disease is characterized by a progressive deposition of sphingolipids in differe...
Fabry's disease is a multisystem X-linked disorder of lysosomal metabolism frequently associated wit...
Abstract Background Cardiac involvement is common and...
Abstract Although Fabry disease was identified a century ago, it is still a challenging condition to...
BackgroundCardiovascular disease is the most common cause of death among Fabry disease patients, who...
In spite of several research studies help to describe the heart in Fabry disease (FD), the cardiomyo...
Skeletal muscle disturbances are commonly reported in patients with Fabry disease. Whether they deri...
Fabry disease (FD) is a genetic lysosomal storage disease with frequent cardiovascular involvement, ...
In the past few years, the wide application of cardiac magnetic resonance (CMR) significantly change...